Advisor Net Financial, Inc Sorrento Therapeutics, Inc. Transaction History

Advisor Net Financial, Inc

  • $1.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022
SELL
$2.0 - $4.9 $2,000 - $4,900
-1,000 Closed
0 $0
Q4 2021

Jan 19, 2022
SELL
$4.65 - $7.23 $2,325 - $3,615
-500 Reduced 33.33%
1,000 $5,000
Q4 2020

Feb 04, 2021
SELL
$5.76 - $11.95 $8,640 - $17,925
-1,500 Reduced 50.0%
1,500 $10,000
Q2 2020

Aug 26, 2020
BUY
$1.73 - $6.76 $5,190 - $20,280
3,000 New
3,000 $19,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email